This is a prospective non-randomized clinical study of 24 patients to evaluate the effects of the AC-11®. The study will evaluate the effectiveness of the supplement's ability to reverse epigenetic markers of biological age. The duration of the study will be 6 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
32
6-months of treatment with AC-11
Thrive Medicine Clinic
Sugar Land, Texas, United States
Methylation age clock testing
Epigenetic testing
Time frame: Change in epigenetic age from baseline to 6 months
Telomere Test
Epigenetic testing
Time frame: Change in telomere length from baseline to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.